Form 8-K - Current report:
SEC Accession No. 0000950170-25-085588
Filing Date
2025-06-12
Accepted
2025-06-12 17:28:14
Documents
12
Period of Report
2025-06-10
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K eldn-20250610.htm   iXBRL 8-K 70571
2 EX-3.1 eldn-ex3_1.htm EX-3.1 16905
3 EX-3.2 eldn-ex3_2.htm EX-3.2 17244
  Complete submission text file 0000950170-25-085588.txt   221016

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT eldn-20250610.xsd EX-101.SCH 25814
14 EXTRACTED XBRL INSTANCE DOCUMENT eldn-20250610_htm.xml XML 4884
Mailing Address 19800 MACARTHUR BLVD. SUITE 250 IRVINE CA 92612
Business Address 19800 MACARTHUR BLVD. SUITE 250 IRVINE CA 92612 949-238-8090
Eledon Pharmaceuticals, Inc. (Filer) CIK: 0001404281 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36620 | Film No.: 251043919
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)